Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.
D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000097:blood; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007668:Kidney / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D008914:Minoxidil / Q000494:pharmacology* / Q000627:therapeutic use; D010477:Perfusion; D011433:Propranolol / Q000097:blood / Q000494:pharmacology*; D011863:Radioimmunoassay; D012039:Regional Blood Flow / Q000187:drug effects; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D000804:Angiotensin II; D008914:Minoxidil; D012964:Sodium; D011433:Propranolol; D003404:Creatinine; D012083:Renin